Drug Trial Radar · NCT05767346
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM
Last checked: Nov 20, 2026Latest source record: Jun 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
175
Actual
Start
Jun 20, 2023
Primary completion
Feb 28, 2025
Study completion Mar 28, 2025
Sponsor
- Lead sponsor
- CytokineticsIndustry
- Sponsor type
- Industry
- Collaborators
- Sanofi
- First posted
- Mar 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy and safety of aficamten (CK-3773274) compared with metoprolol succinate in adults with symptomatic hypertrophic cardiomyopathy and left ventricular outflow tract obstruction
Conditions
- Obstructive Hypertrophic Cardiomyopathy (oHCM)
Interventions
Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)Drug
Aficamten (CK-3773274) tablets administered orally
Placebo to match aficamtenDrug
Placebo for aficamten (CK-3773274) administered orally
Metoprolol succinate (50 mg, 100 mg, 150 mg and 200 mg)Drug
Metoprolol succinate tablets administered orally
Placebo to match metoprolol succinateDrug
Placebo for metoprolol succinate administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Peak Oxygen Uptake (pVO2) by Cardiopulmonary Exercise Testing (CPET)Time frame: Baseline to Week 24
Locations
71 sites in 13 countries. Site status is shown where the registry gives one.
Alaska Heart and Vascular Institute
Anchorage, Alaska
Mayo Clinic
Phoenix, Arizona
UC San Diego Health - Sulpizio Cardiovascular Center
La Jolla, California
Cedars-Sinai Medical Center (Smidt Heart Institute)
Los Angeles, California
Yale New Haven Hospital
New Haven, Connecticut
AdventHealth
Orlando, Florida
Emory Clinic
Atlanta, Georgia
Piedmont Fayette Hospital
Fayetteville, Georgia
Northwestern University
Evanston, Illinois
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
Lahey Hospital & Medical Center
Burlington, Massachusetts
Henry Ford Hospital
Detroit, Michigan
Saint Luke's Hospital of Kansas City
Kansas City, Missouri
Morristown Medical Center
Morristown, New Jersey
Columbia University Medical Center/New York Presbyterian Hospital
New York, New York
Sanger Heart & Vascular Institute - HCM Clinic
Charlotte, North Carolina
Duke Health Center Arringdon
Morrisville, North Carolina
Providence St. Vincent Medical Center
Portland, Oregon
Oregon Health & Science University
Portland, Oregon
Division of Heart Failure and Transplantation (Hospital of the University of Pennsylvania)
Philadelphia, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Ascension Saint Thomas Heart West
Nashville, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee
CHI St. Luke's Health Baylor-St. Luke's Medical Center
Houston, Texas
Houston Methodist Hospital
Houston, Texas
Intermountain Medical Center
Murray, Utah
Inova Schar Heart and Vascular
Falls Church, Virginia
Institutdo Danta Pazzanese
Ibirapuera, Brazil
Instituto de Pesquisa Clinica de Campinas - IPECC
Campinas, São Paulo, Brazil
lnstituto do Coracao do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, São Paulo, Brazil
Institut universitaire de cardiologie et de pneumonlogie de Quebec - Universite Laval
Québec, Canada
Xiangya Second Hospital of Central South University
Changsha, China
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, China
Guangdong Provincial People's Hospital
Guangzhou, China
Zhongshan Hospital Fudan University
Shanghai, China
Renmin Hospital of Wuhan University
Wuhan, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
Aarhus University Hospital
Aarhus, Denmark
Copenhagen University Hospital
Copenhagen, Denmark
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.